​
​

Cyclerion Therapeutics Ownership 2024 | Who Owns Cyclerion Therapeutics Now?

OverviewFinancialsChart

Institutional Ownership

0.02%

Insider Ownership

21.90%

Retail Ownership

78.07%

Institutional Holders

1.00

Cyclerion Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.----552-100.00%-Dec 31, 2023

Cyclerion Therapeutics's largest institutional shareholder is ARTAL GROUP S.A., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.----552-100.00%-Dec 31, 2023

The largest Cyclerion Therapeutics shareholder by % of total assets is ARTAL GROUP S.A.. The company owns 0.00 shares of Cyclerion Therapeutics (CYCN), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.----552-100.00%-Dec 31, 2023

As of Dec 31 2023, Cyclerion Therapeutics's largest institutional buyer is ARTAL GROUP S.A.. The company purchased -0.55K stocks of CYCN, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.----552-100.00%-Dec 31, 2023

As of Dec 31 2023, Cyclerion Therapeutics's biggest institutional seller is ARTAL GROUP S.A.. The company sold -0.55K shares of CYCN, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.----552-100.00%-Dec 31, 2023

Cyclerion Therapeutics's largest sold out institutional shareholder by shares sold is ARTAL GROUP S.A., sold -0.55K shares, valued at -, as of undefined.

Cyclerion Therapeutics Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
T. Rowe Price Health Sciences Fund, Inc.0.17%579,827--Mar 31, 2024
UBS RELATIONSHIP FUNDS0.10%23,269--Jun 30, 2020
FIDELITY COMMONWEALTH TRUST0.07%227,375--Feb 29, 2024
Brown Capital Management Mutual Funds0.06%174,196--Dec 31, 2023
BRIDGEWAY FUNDS INC0.05%107,000--Mar 28, 2024
VANGUARD VALLEY FORGE FUNDS0.04%23,450--Mar 31, 2024
FIDELITY MT VERNON STREET TRUST0.03%795,260--Feb 29, 2024
VANGUARD SPECIALIZED FUNDS0.02%989,481--Jan 31, 2024
T. Rowe Price Equity Series, Inc.0.02%26,300--Mar 31, 2024
Vericimetry Funds0.02%1,400--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.01%837,285--Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.01%38,797--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%3,714--Mar 31, 2024
VANGUARD EXPLORER FUND0.01%73,838--Jan 31, 2024
UBS FUNDS0.01%28,574--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%13,8408536.57%Feb 29, 2024
VANGUARD INDEX FUNDS0.00%1,608,075--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.00%31,721--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%528--Mar 31, 2024
BRIDGEWAY FUNDS INC0.00%5,350--Mar 28, 2024
JNL VARIABLE FUND LLC0.00%11,107--Mar 31, 2020
FIDELITY CONCORD STREET TRUST0.00%341,933--Feb 29, 2024
FIDELITY MT VERNON STREET TRUST0.00%32,351-2,226-6.44%Feb 29, 2024
T. Rowe Price New Horizons Fund, Inc.0.00%4,330--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%26,426--Mar 31, 2024
Calvert Variable Products, Inc.0.00%2,036--Mar 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%37,118--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%41,864--Feb 29, 2024
Nushares ETF Trust0.00%3,649--Jan 31, 2024
Fidelity Commonwealth Trust II0.00%2,954--Aug 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%12,043--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%15,496--Feb 29, 2024
GPS Funds I0.00%1,918--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%29,104--Jan 31, 2024
SunAmerica Specialty Series0.00%183--Apr 30, 2021
PFM Multi-Manager Series Trust0.00%260--Dec 31, 2023
FIDELITY COVINGTON TRUST0.00%5,552--Jan 31, 2024
HARTFORD SERIES FUND INC0.00%12,257--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%151,796--Feb 29, 2024
VANGUARD WORLD FUND0.00%54,046--Feb 29, 2024
Columbia Funds Variable Series Trust II0.00%4,848--Mar 31, 2024
Meeder Funds0.00%733--Mar 31, 2024
HC CAPITAL TRUST0.00%4,348--Mar 31, 2024
JOHN HANCOCK INVESTMENT TRUST0.00%10,043--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,070--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%16,885-47-0.28%Feb 29, 2024
NORTHERN FUNDS0.00%11,633--Mar 28, 2024
TIAA-CREF LIFE FUNDS0.00%208--Mar 31, 2024
PGIM ETF TRUST0.00%4,406--Feb 29, 2024
ALLSPRING MASTER TRUST0.00%4,290--Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%3,740--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%23,490-23,490-50.00%Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%169,863--Mar 31, 2024
ProFunds0.00%481--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%43,203--Mar 31, 2024
PACE SELECT ADVISORS TRUST0.00%12,599--Jan 31, 2024
VALIC Co I0.00%10,513--Feb 29, 2024
PENN SERIES FUNDS INC0.00%976--Mar 28, 2024
VANGUARD SCOTTSDALE FUNDS0.00%66,264--Feb 29, 2024
RUSSELL INVESTMENT CO0.00%9,911--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%3,820--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%3,225--Jan 31, 2024
RUSSELL INVESTMENT FUNDS0.00%2,399--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%3,849--Jan 31, 2024
SPDR INDEX SHARES FUNDS0.00%3,254--Mar 31, 2024
Brighthouse Funds Trust II0.00%12,605--Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%28,487--Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%993--Feb 29, 2024
Legg Mason Global Asset Management Trust0.00%75,786--Jan 31, 2024
HARTFORD MUTUAL FUNDS INC/CT0.00%77,471--Jan 31, 2024
T. Rowe Price Index Trust, Inc.0.00%198--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%8,757--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%3,133--Mar 31, 2024
EQ ADVISORS TRUST0.00%6,103--Mar 31, 2024
PACIFIC SELECT FUND0.00%16,928--Mar 31, 2024
ADVANCED SERIES TRUST0.00%14,100--Mar 28, 2024
Blackstone Alternative Investment Funds0.00%200--Mar 31, 2023
iShares U.S. ETF Trust0.00%330--Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%2,767--Dec 31, 2023
Bridge Builder Trust0.00%8,810--Mar 31, 2024
J.P. Morgan Exchange-Traded Fund Trust0.00%740--Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%2,735--Mar 31, 2024
John Hancock Funds II0.00%15,848--Feb 29, 2024
iSHARES TRUST0.00%16,580--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%209--Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%3,184--Mar 31, 2024
Legg Mason Global Asset Management Trust0.00%3,789--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%156--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%2,315--Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC0.00%100--Dec 31, 2023
BLACKROCK FUNDS0.00%1,865--Mar 28, 2024
Advisors' Inner Circle Fund III0.00%17--Jan 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%2,425--Feb 29, 2024

Cyclerion Therapeutics's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 579.83K shares, compromising 0.17% of its total assets.

Cyclerion Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 231-
30 Jun, 231-97.06%
31 Mar, 2334-17.07%
31 Dec, 224128.13%
30 Sep, 2232-11.11%
30 Jun, 2236-20.00%
31 Mar, 2245-15.09%
31 Dec, 2153-11.67%
30 Sep, 2160-9.09%
30 Jun, 2166-5.71%
31 Mar, 21701.45%
31 Dec, 2069-
30 Sep, 2069-1.43%
30 Jun, 2070-1.41%
31 Mar, 2071-
31 Dec, 1971-17.44%
30 Sep, 1986-9.47%
30 Jun, 19952275.00%
31 Mar, 194-

As of 30 Sep 23, 1 institutions are holding Cyclerion Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 23552-
30 Jun, 23552-100.00%
31 Mar, 2320,630,091-0.95%
31 Dec, 2220,827,663-1.93%
30 Sep, 2221,238,2281.59%
30 Jun, 2220,905,151-8.94%
31 Mar, 2222,957,892-2.60%
31 Dec, 2123,569,938-4.15%
30 Sep, 2124,589,2430.32%
30 Jun, 2124,510,8319.43%
31 Mar, 2122,398,0272.51%
31 Dec, 2021,850,647-5.70%
30 Sep, 2023,172,31130.89%
30 Jun, 2017,703,947-4.46%
31 Mar, 2018,531,14320.46%
31 Dec, 1915,383,273-21.30%
30 Sep, 1919,547,9390.81%
30 Jun, 1919,391,7232167.89%
31 Mar, 19855,056-

Cyclerion Therapeutics (CYCN) has 552.00 shares outstanding as of 30 Sep 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 230.02%3754.33%
30 Jun, 230.03%0.00%
31 Mar, 2347.40%2.07%
31 Dec, 2247.86%2.01%
30 Sep, 2248.80%2.11%
30 Jun, 2248.03%1.73%
31 Mar, 2252.75%0.88%
31 Dec, 2177.53%1.19%
30 Sep, 2180.88%1.24%
30 Jun, 2180.62%1.49%
31 Mar, 2173.67%1.43%
31 Dec, 2071.87%1.24%
30 Sep, 2076.22%1.82%
30 Jun, 2064.66%1.41%
31 Mar, 2067.68%2.14%
31 Dec, 1956.18%1.10%
30 Sep, 1971.39%1.42%
30 Jun, 1970.82%1.82%
31 Mar, 1962.46%-

As of 30 Sep 23, Cyclerion Therapeutics is held by 0.02% institutional shareholders, representing a 3754.33% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 237-63.16%
31 Dec, 2219216.67%
30 Sep, 226-50.00%
30 Jun, 2212-14.29%
31 Mar, 2214-36.36%
31 Dec, 2122-15.38%
30 Sep, 2126-10.34%
30 Jun, 2129-14.71%
31 Mar, 2134-5.56%
31 Dec, 203624.14%
30 Sep, 2029-
30 Jun, 2029-14.71%
31 Mar, 2034-10.53%
31 Dec, 1938-9.52%
30 Sep, 1942-54.35%
30 Jun, 19922200.00%
31 Mar, 194-

- institutional shareholders have increased their position in CYCN stock as of 30 Sep 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 23--100.00%
30 Jun, 231-92.31%
31 Mar, 231362.50%
31 Dec, 228-27.27%
30 Sep, 2211-
30 Jun, 2211-38.89%
31 Mar, 221850.00%
31 Dec, 2112-36.84%
30 Sep, 2119-5.00%
30 Jun, 212025.00%
31 Mar, 2116-11.11%
31 Dec, 2018-25.00%
30 Sep, 2024-4.00%
30 Jun, 202513.64%
31 Mar, 202229.41%
31 Dec, 1917-
30 Sep, 1917750.00%
30 Jun, 192-
31 Mar, 19--

- institutional shareholders have reduced their position in CYCN stock as of 30 Sep 23 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 231-552-0.02%3754.33%----100.00%
30 Jun, 231-97.06%552-100.00%0.03%0.00%--100.00%1-92.31%
31 Mar, 2334-17.07%20,630,091-0.95%47.40%2.07%7-63.16%1362.50%
31 Dec, 224128.13%20,827,663-1.93%47.86%2.01%19216.67%8-27.27%
30 Sep, 2232-11.11%21,238,2281.59%48.80%2.11%6-50.00%11-
30 Jun, 2236-20.00%20,905,151-8.94%48.03%1.73%12-14.29%11-38.89%
31 Mar, 2245-15.09%22,957,892-2.60%52.75%0.88%14-36.36%1850.00%
31 Dec, 2153-11.67%23,569,938-4.15%77.53%1.19%22-15.38%12-36.84%
30 Sep, 2160-9.09%24,589,2430.32%80.88%1.24%26-10.34%19-5.00%
30 Jun, 2166-5.71%24,510,8319.43%80.62%1.49%29-14.71%2025.00%
31 Mar, 21701.45%22,398,0272.51%73.67%1.43%34-5.56%16-11.11%
31 Dec, 2069-21,850,647-5.70%71.87%1.24%3624.14%18-25.00%
30 Sep, 2069-1.43%23,172,31130.89%76.22%1.82%29-24-4.00%
30 Jun, 2070-1.41%17,703,947-4.46%64.66%1.41%29-14.71%2513.64%
31 Mar, 2071-18,531,14320.46%67.68%2.14%34-10.53%2229.41%
31 Dec, 1971-17.44%15,383,273-21.30%56.18%1.10%38-9.52%17-
30 Sep, 1986-9.47%19,547,9390.81%71.39%1.42%42-54.35%17750.00%
30 Jun, 19952275.00%19,391,7232167.89%70.82%1.82%922200.00%2-
31 Mar, 194-855,056-62.46%-4---

Cyclerion Therapeutics Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 11, 2023MCGUIRE TERRANCEdirector-S-SaleSell8$3.40$27.16-

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 11, 2024CHICKO RHONDA M.officer Chief Financial OfficerSell---18
Dec 11, 2023Katabi Dinadirector-Sell---20,000
Dec 07, 2023Higgins Michael Jdirector-Sell---21,650
Dec 07, 2023Graul Regina Margaretofficer PresidentSell---50,303
Dec 04, 2023Graul Regina Margaretofficer PresidentSell---50,000
Aug 11, 2023MCGUIRE TERRANCEdirector-S-SaleSell8$3.40$27.16-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 07, 2024Graul Regina Margaretdirector, officer See RemarksA-AwardBuy55,849$3.30$184.30K55,849
Mar 11, 2024CHICKO RHONDA M.officer Chief Financial OfficerSell---18
Jan 26, 2024Hecht Peter Mdirector, 10 percent owner A-AwardBuy15,000--377,385
Jan 26, 2024Graul Regina Margaretofficer PresidentA-AwardBuy50,000--100,303
Dec 11, 2023Katabi Dinadirector-Sell---20,000
Dec 07, 2023Higgins Michael Jdirector-Sell---21,650
Dec 07, 2023Graul Regina Margaretofficer PresidentSell---50,303
Dec 04, 2023Graul Regina Margaretofficer PresidentSell---50,000
Dec 04, 2023MCGUIRE TERRANCEdirector-A-AwardBuy5,000--5,552
Dec 04, 2023Hecht Peter Mdirector, 10 percent owner A-AwardBuy15,000--362,385
Dec 04, 2023Hecht Peter Mdirector, 10 percent owner A-AwardBuy20,000--347,385
Dec 04, 2023DESOUZA ERROL Bdirector-A-AwardBuy20,000--50,000
Dec 04, 2023DESOUZA ERROL Bdirector-A-AwardBuy30,000--30,000
Dec 04, 2023Hyman Stevendirector-A-AwardBuy20,000--20,000
Aug 11, 2023MCGUIRE TERRANCEdirector-S-SaleSell8$3.40$27.16-
May 22, 2023Hecht Peter Mdirector, 10 percent owner, officer Chief Executive OfficerA-AwardBuy351,037--351,037
May 22, 2023Hecht Peter Mdirector, 10 percent owner, officer Chief Executive OfficerA-AwardBuy225,000$8.68$1.95M327,385
Jul 27, 2022Hyman Stevendirector-A-AwardBuy57,753$0.78$45.05K57,753
Jul 26, 2022Hyman Stevendirector A-AwardBuy57,753--57,753
Jun 16, 2022MCGUIRE TERRANCEdirector-A-AwardBuy20,000$0.53$10.60K20,000

The last insider sell of Cyclerion Therapeutics's stock was made by CHICKO RHONDA M. on Mar 11 2024, selling - shares at - per share (valued at -).

Cyclerion Therapeutics Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20241--
Q1 202421200.00%
Q4 202364150.00%
Q3 2023-1-
Q2 20232--
Q3 20222--
Q2 202212--
Q1 20225--
Q4 20213--
Q2 20211711700.00%
Q1 2021-35-
Q4 202031030.00%
Q3 2020---
Q2 20208--
Q1 202011100.00%
Q4 201953166.67%
Q3 201911100.00%
Q2 20198218200.00%
Q1 201911100.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cyclerion Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q1 2024---
Q4 2023---
Q3 2023-1-
Q2 2023---
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q2 20219--
Q1 2021-2-
Q4 202022100.00%
Q3 2020---
Q2 2020---
Q1 2020-1-
Q4 20191333.33%
Q3 2019---
Q2 20195--
Q1 2019---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cyclerion Therapeutics's stocks.

Cyclerion Therapeutics Peer Ownership

TickerCompany
SNTISenti Biosciences, Inc.
ZVSAZyVersa Therapeutics, Inc.
MGTADianthus Therapeutics, Inc.
XFORX4 Pharmaceuticals, Inc.
CFRXContraFect Corporation
AXLAAxcella Health Inc.
MNPRMonopar Therapeutics Inc.
ACHLAchilles Therapeutics plc
LRMRLarimar Therapeutics, Inc.
ERASErasca, Inc.
FENCFennec Pharmaceuticals Inc.
SGTXSigilon Therapeutics, Inc.
KRONKronos Bio, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.
LIPOLipella Pharmaceuticals Inc.
ADXNAddex Therapeutics Ltd
KZRKezar Life Sciences, Inc.
FBRXForte Biosciences, Inc.
CDIOCardio Diagnostics Holdings, Inc.

CYCN Ownership FAQ

Cyclerion Therapeutics is owned by institutional shareholders (0.02%), insiders (21.90%), and public (78.07%). The largest institutional shareholder of Cyclerion Therapeutics is ARTAL GROUP S.A. (0% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.17% of total shares).

Cyclerion Therapeutics's major institutional shareholders are ARTAL GROUP S.A.. The top five shareholders own together 0% of the company's share outstanding.

As of Sep 2023, there are 1 institutional shareholders of Cyclerion Therapeutics.

ARTAL GROUP S.A owns 0 shares of Cyclerion Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).